Retatrutide in Michigan (2026)
retatrutide · GLP-1 weight management · Michigan
About Retatrutide
Investigational triple agonist (GLP-1 / GIP / glucagon). Phase 3 weight loss approached ~24%, the highest yet. Not FDA-approved; expected 2027.
See the full Retatrutide review for dosing, efficacy data, side effects, and the full pharmacy + telehealth program comparison.
Insurance coverage for Retatrutide in Michigan
Since January 1, 2026, Michigan Medicaid covers GLP-1s for obesity only for morbid obesity, after documented failure of other weight-loss interventions including PDL-preferred anti-obesity drugs, and only to avoid bariatric surgery. Prior authorizations approved before the change stay valid until their 6-month term ends.
We do not track carrier-level coverage for Retatrutide. Check your plan's formulary or our insurance hub.
Telehealth and prescribing in Michigan
A telehealth clinician must be licensed in Michigan to prescribe Retatrutide to you while you are in Michigan.
Michigan's IMLC membership lapsed on March 28, 2025 and was restored by Public Act 6 of 2026 (HB 5455), signed March 26, 2026.
- Source: Michigan Legislature: HB 5455
Platforms differ in which drugs they prescribe, insurance handling, and clinical model. See our platform comparisons.
Compounded retatrutide
On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.
Retatrutide in Michigan: common questions
Is Retatrutide legal in Michigan?+
Yes. Retatrutide (retatrutide) is FDA-approved and legal in all 50 US states including Michigan. State-level differences appear in Medicaid coverage and clinician licensing, not in the legality of the medication itself.
Can I get Retatrutide via telehealth in Michigan?+
Yes, from a clinician licensed in Michigan. A telehealth clinician must be licensed in Michigan to prescribe Retatrutide to you while you are in Michigan. Michigan's IMLC membership lapsed on March 28, 2025 and was restored by Public Act 6 of 2026 (HB 5455), signed March 26, 2026.
Does Michigan Medicaid cover Retatrutide?+
Limited coverage for weight loss. Since January 1, 2026, Michigan Medicaid covers GLP-1s for obesity only for morbid obesity, after documented failure of other weight-loss interventions including PDL-preferred anti-obesity drugs, and only to avoid bariatric surgery. Prior authorizations approved before the change stay valid until their 6-month term ends.
What's the cheapest way to get Retatrutide in Michigan?+
The main paths are insurance with prior authorization if your plan covers it, manufacturer cash-pay programs, or telehealth programs that include the medication. NovoCare Pharmacy sells Wegovy pens to cash-pay patients for $349 a month ($199 a month for the first two months for new patients through December 31, 2026). LillyDirect sells Zepbound vials for $299 (2.5 mg), $399 (5 mg), and $449 (7.5 to 15 mg) a month when refilled on time.
Is compounded Retatrutide still available in Michigan?+
Compounding rules are federal, not set by Michigan. On April 30, 2026, FDA proposed not to include semaglutide, tirzepatide, and liraglutide on the 503B bulks list, which would stop outsourcing facilities from compounding them from bulk ingredients. The comment period was extended to July 30, 2026. As of September 15, 2026, no final decision has been published. The proposal does not address 503A compounding for an individual patient's documented clinical need.